Literature DB >> 29713098

Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia.

Srinagesh Mannekote Thippaiah1, Soumya Nagaraja1, Badari Birur1, Ananda Pandurangi1.   

Abstract

Stuttering Priapism is a recurrent, persistent penile erection in the absence of sexual desire due to altered genital hemodynamics, affecting the arterial component (high flow, non-ischemic) or the veno-occlusive mechanism (low flow, ischemic). Both typical and atypical antipsychotics increase the risk for priapism with greater implications in typicals than atypicals. Prompt recognition and treatment are important as 40% to 50% of patients with stuttering priapism may develop an erectile dysfunction if left untreated. There are several case reports in the literature about the association between psychotropic agents and priapism. However, there are no reports of successfully treating stuttering priapism using pseudoephedrine (sudafed) in the adult population. Here we present successful management of psychotropics induced stuttering priapism with pseudoephedrine in a male patient with schizophrenia.

Entities:  

Keywords:  genital hemodynamics; pseudoephedrine; psychotropics; schizophrenia; stuttering priapism

Mesh:

Substances:

Year:  2018        PMID: 29713098      PMCID: PMC5875360     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  10 in total

Review 1.  Receptor pharmacology of neuroleptics: relation to clinical effects.

Authors:  E Richelson
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

2.  American Urological Association guideline on the management of priapism.

Authors:  Drogo K Montague; Jonathan Jarow; Gregory A Broderick; Roger R Dmochowski; Jeremy P W Heaton; Tom F Lue; Ajay Nehra; Ira D Sharlip
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

3.  The use of sudafed for priapism in pediatric patients with sickle cell disease.

Authors:  Morgan Mocniak; Christina Marie Durkin; Kenneth Early
Journal:  J Pediatr Nurs       Date:  2012-02       Impact factor: 2.145

Review 4.  Psychotropic medication and priapism: a comprehensive review.

Authors:  J W Thompson; M R Ware; R K Blashfield
Journal:  J Clin Psychiatry       Date:  1990-10       Impact factor: 4.384

5.  Delayed-onset of psychopharmacologically induced priapism: A cautionary case report.

Authors:  Badari Birur; Rachel E Fargason; Norman Moore
Journal:  Asian J Psychiatr       Date:  2015-06-29

6.  Priapism associated with typical and atypical antipsychotic medications.

Authors:  Chien-Shu Wang; Wei-Tsung Kao; Chian-Dar Chen; Yu-Ping Tung; For-Wey Lung
Journal:  Int Clin Psychopharmacol       Date:  2006-07       Impact factor: 1.659

7.  Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.

Authors:  Neel Patel; Katherine B Landry; Rachel E Fargason; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2017-01-26

8.  Incidence of priapism in the general population.

Authors:  I A Eland; J van der Lei; B H Stricker; M J Sturkenboom
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

Review 9.  Stuttering priapism--a review of the therapeutic options.

Authors:  A Muneer; S Minhas; M Arya; D J Ralph
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

10.  Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity.

Authors:  Frank Andersohn; Niklas Schmedt; Stefan Weinmann; Stefan N Willich; Edeltraut Garbe
Journal:  J Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.